89bio Balance Sheet Health

Financial Health criteria checks 5/6

89bio has a total shareholder equity of $514.9M and total debt of $25.1M, which brings its debt-to-equity ratio to 4.9%. Its total assets and total liabilities are $582.1M and $67.2M respectively.

Key information

4.9%

Debt to equity ratio

US$25.13m

Debt

Interest coverage ration/a
CashUS$531.38m
EquityUS$514.92m
Total liabilitiesUS$67.22m
Total assetsUS$582.14m

Recent financial health updates

Recent updates

Health Check: How Prudently Does 89bio (NASDAQ:ETNB) Use Debt?

Sep 26
Health Check: How Prudently Does 89bio (NASDAQ:ETNB) Use Debt?

89bio: Bullish In Light Of Further MOA Being Established By Peer

Aug 07

89bio: Pegozafermin Could Be A Game-Changer For Liver Disease - Strong Buy

May 23

89bio Still Has A Chance As NASH Race Heats Up

Oct 06

89bio completes enrollment in phase 2 trial for NASH treatment

Aug 18

89Bio rallies on Deep Track Capital disclosing 10% stake

Jul 07

89bio: Undervalued Contender In Race For First NASH Drug Approval

Jul 20

We're Hopeful That 89bio (NASDAQ:ETNB) Will Use Its Cash Wisely

May 07
We're Hopeful That 89bio (NASDAQ:ETNB) Will Use Its Cash Wisely

89bio: NASH Drug Developer With Differentiated Profile

Jan 29

We're Hopeful That 89bio (NASDAQ:ETNB) Will Use Its Cash Wisely

Jan 22
We're Hopeful That 89bio (NASDAQ:ETNB) Will Use Its Cash Wisely

89bio expects to initiate Phase 2b NASH trial in 1H21

Jan 05

Financial Position Analysis

Short Term Liabilities: ETNB's short term assets ($579.9M) exceed its short term liabilities ($41.7M).

Long Term Liabilities: ETNB's short term assets ($579.9M) exceed its long term liabilities ($25.6M).


Debt to Equity History and Analysis

Debt Level: ETNB has more cash than its total debt.

Reducing Debt: ETNB's debt to equity ratio has increased from 0% to 4.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ETNB has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: ETNB has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 35.2% each year.


Discover healthy companies